GSK and Theravance announce positive results from studies comparing ANORO™ ELLIPTA™ with SERETIDE® DISKUS®and ADVAIR® DISKUS® in patients with COPD GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, ...
Seretide/Advair is GSK’s best-selling drug, and the line was extended in 2003 when the European Union approved the higher-dose 500 Accuhaler for the symptomatic treatment of severe COPD, i.e., ...
Is there a generic product available that I can use instead of my Seretide 50/500? I have been diagnosed with chronic asthma and must use 2 inhalations daily but I find the cost prohibitive. Thank you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback